MYP_111329
Basic Information
Unnamed
Antimicrobial
Antiviral
Antiviral Antiviral mechanism Viral entry inhibition Entry inhibitor
Standard
27 amino acids
C135H203N33O50S3
Standard
Sequence
HMNASDMEIKSYINMIESVEESSNYDF
Physicochemical Analysis
3184.44 Da
4.08
-5.14
-5.41
-0.1905
-0.64
0.57
-0.02
69.34
57.78
0.1111
2980.00
2980.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1369.30
-14.69
46.0
49.0
108.0
221.0
4.0
29.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0019616 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 0.0%, E 0.0%, T 63.0%, C 37.0% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
RECORD: Rec_0061922 VERIFIED: YES
Provenance & Taxonomy
Gallid alphaherpesvirus 2 [Virus]
Virus-derived peptide
10390;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor
Marek's disease virus (Virus entry); CEF
4100 μM
Plaque assay
RECORD: Rec_0395803 VERIFIED: YES
Provenance & Taxonomy
Gallid alphaherpesvirus 2 [Virus]
Virus-derived peptide
10390;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor
Marek's disease virus (Virus entry); CEF
4 μM
Plaque assay